What is the recommended treatment for herpes, a sexually transmitted disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Herpes Sexually Transmitted Disease

The recommended first-line treatment for genital herpes is valacyclovir 1000 mg three times daily for initial episodes, or 500 mg twice daily for recurrent episodes, with suppressive therapy of 500-1000 mg once daily for frequent recurrences. 1

Antiviral Treatment Options

Initial Episode of Genital Herpes

  • First-line treatment options:
    • Valacyclovir 1000 mg orally three times daily for 7-10 days 1
    • Acyclovir 800 mg orally five times daily for 7-10 days 2
    • Famciclovir (alternative option) 3

Recurrent Episodes of Genital Herpes

  • Treatment options:
    • Valacyclovir 500 mg twice daily for 3 days 1, 4
    • Acyclovir 800 mg orally three times daily for 2 days 5
    • Treatment should be initiated within 24 hours of symptom onset for maximum effectiveness 1

Suppressive Therapy

  • For patients with frequent recurrences (≥6 episodes per year):
    • Valacyclovir 500-1000 mg once daily 1, 6
    • For patients with <10 recurrences per year: 500 mg once daily is effective 6
    • For patients with ≥10 recurrences per year: 1000 mg once daily is recommended 6
  • Suppressive therapy reduces:
    • Frequency of outbreaks by 70-80%
    • Severity and duration of breakthrough episodes
    • Asymptomatic viral shedding 2
    • Risk of transmission to sexual partners 1

Special Considerations

Pregnant Women

  • Acyclovir is the first-line treatment during pregnancy due to its established safety profile 2
  • Dosage: 800 mg orally 5 times daily 2
  • Treatment should be initiated within 72 hours of symptom onset 2
  • Acyclovir has not been associated with increased risk of major birth defects 2, 7

Immunocompromised Patients

  • May require higher doses and longer treatment duration 2
  • For HIV-infected patients with CD4+ counts <200 cells/μL, higher oral doses are recommended 2
  • Close monitoring for treatment response is essential 2

Severe Cases

  • Intravenous acyclovir 10 mg/kg every 8 hours may be required 2
  • For acyclovir-resistant infections, foscarnet 40 mg/kg IV 3 times daily is recommended 2

Treatment Timing and Follow-up

  • Antiviral therapy should be initiated as soon as possible after symptom onset:
    • Within 72 hours for initial episodes 2
    • Within 24 hours for recurrent episodes 1
  • Early treatment significantly reduces:
    • Duration of viral shedding
    • Time to lesion healing
    • Severity of symptoms 8
  • Follow-up within 7 days is recommended to assess:
    • Treatment response
    • Complete resolution of lesions
    • Signs of complications 2

Pain Management

  • For mild pain: acetaminophen or NSAIDs 2
  • For moderate to severe pain: consider gabapentin, pregabalin, or tricyclic antidepressants 2
  • Topical options for localized pain: lidocaine patches or 2% viscous lidocaine 2

Prevention and Patient Education

  • Safer sex practices should be used even with suppressive therapy 1
  • Patients should be counseled about:
    • The chronic nature of the infection
    • Potential for asymptomatic viral shedding
    • Risk of transmission to sexual partners
    • Importance of adherence to treatment regimens 4, 7

The once-daily dosing regimen of valacyclovir for suppressive therapy offers a convenient option that may improve patient adherence compared to multiple daily doses required with acyclovir 4, 6.

References

Guideline

Herpes Zoster Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Valacyclovir for the treatment of genital herpes.

Expert review of anti-infective therapy, 2006

Research

Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002

Research

Antiviral therapy for genital herpes in nonpregnant and pregnant women.

International journal of fertility and women's medicine, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.